Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
gptkb:European_Union
|
| gptkbp:ATCCode |
gptkb:N05AX12
|
| gptkbp:brand |
gptkb:Melitor
gptkb:Thymanax gptkb:Valdoxan |
| gptkbp:CASNumber |
gptkb:132539-06-1
|
| gptkbp:compatibleWith |
gptkb:United_States
|
| gptkbp:developedBy |
gptkb:Servier_Laboratories
|
| gptkbp:discoveredIn |
1990s
|
| gptkbp:hasMolecularFormula |
C21H23ClN2O2
|
| https://www.w3.org/2000/01/rdf-schema#label |
D08402
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
2009
|
| gptkbp:mechanismOfAction |
5-HT2C receptor antagonist
melatonin receptor agonist |
| gptkbp:pregnancyCategory |
gptkb:C_(Australia)
|
| gptkbp:PubChem_CID |
gptkb:D08402
6918493 DB09213 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
dizziness headache liver toxicity |
| gptkbp:synonym |
gptkb:agomelatine
|
| gptkbp:usedFor |
gptkb:major_depressive_disorder
|
| gptkbp:bfsParent |
gptkb:riluzole
|
| gptkbp:bfsLayer |
5
|